Metabolomics in pediatric nephrology: emerging concepts

Pediatric Nephrology

Volumn 30, Issue 6, 2015, Pages 881-887

  Hanna, Mina H ^a   Brophy, Patrick D ^b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Biomarkers; Metabolomics; Pediatric nephrology

Indexed keywords

BIOLOGICAL MARKER;

HUMAN; KIDNEY DISEASES; KIDNEY FUNCTION TEST; MASS COMMUNICATION; METABOLISM; METABOLOMICS; NEPHROLOGY; PEDIATRICS; PREDICTIVE VALUE; PROGNOSIS; TRENDS;

BIOMARKERS; DIFFUSION OF INNOVATION; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; METABOLOMICS; NEPHROLOGY; PEDIATRICS; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84939891345     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-014-2880-x     Document Type: Review

References (26)

1. Dettmer K, Hammock BD (2004) Metabolomics—a new exciting field within the “omics” sciences. Environ Health Perspect 112:A396–A397
2. Nicholson JK, Lindon JC, Holmes E (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29:1181–1189
3. Lindon JC, Nicholson JK (2008) Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem 1:45–69
4. Schnackenberg K, Beger RD (2006) Monitoring the health to disease continuum with global metabolic profiling and systems biology. Pharmacogenomics 7:1077–1086
5. Feng X, Liu X, Luo Q, Liu BF (2008) Mass spectrometry in systems biology: an overview. Mass Spectrom Rev 27:635–660
6. Pan Z, Raftery D (2007) Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem 387:525–527
7. Syggelou A, Iacovidou N, Atzori L, Xanthos T, Fanos V (2012) Metabolomics in the developing human being. Pediatr Clin North Am 59(5):1039–1058
8. Xia J, Psychogios N, Young N, Wishart DS (2009) MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 37:W652–660
9. Chadeau-Hyam M, Campanella G, Jombart T, Bottolo L, Portengen L, Vineis P, Liquet B, Vermeulen RC (2013) Deciphering the complex: methodological overview of statistical models to derive OMICS-based biomarkers. Environ Mol Mutagen 54(7):542–557
10. Biomarkers Definition Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95
11. Weiss RH, Kim K (2011) Metabolomics in the study of kidney diseases. Nat Rev Nephrol 8(1):22–33
12. Fukui Y, Kato M, Inoue Y, Matsubara A, Itoh K (2009) A metabonomic approach identifies human urinary phenylacetylglutamine as a novel marker of interstitial cystitis. J Chromatogr B Analyt Technol Biomed Life Sci 877(30):3806–3812
13. Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Böger CA, Banas B, Eckardt KU, Oefner PJ (2011) Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int 79(11):1244–1253
14. Nevedomskaya E, Pacchiarotta T, Artemov A, Meissner A, van Nieuwkoop C, van Dissel JT, Mayboroda OA, Deelder AM (2012) (1)H NMR-based metabolic profiling of urinary tract infection: combining multiple statistical models and clinical data. Metabolomics 8(6):1227–1235
15. Sato E, Kohno M, Yamamoto M, Fujisawa T, Fujiwara K, Tanaka N (2011) Metabolomic analysis of human plasma from haemodialysis patients. Eur J Clin Invest 41(3):241–255
16. Boudonck KJ, Mitchell MW, Nemet L, Keresztes L, Nyska A, Shinar D, Rosenstock M (2009) Discovery of metabolomics biomarkers for early detection of nephrotoxicity. Toxicol Pathol 37(3):280–292
17. Sieber M, Hoffmann D, Adler M, Vaidya VS, Clement M, Bonventre JV, Zidek N, Rached E, Amberg A, Callanan JJ, Dekant W, Mally A (2009) Comparative analysis of novel noninvasive renal biomarkers and metabonomic changes in a rat model of gentamicin nephrotoxicity. Toxicol Sci 109(2):336–349
18. Beger RD, Sun J, Schnackenberg LK (2010) Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicol Appl Pharmacol 243(2):154–166
19. Gao X, Chen W, Li R, Wang M, Chen C, Zeng R, Deng Y (2012) Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum. BMC Syst Biol 6(1):S14
20. Hanna MH, Segar JL, Teesch LM, Kasper DC, Schaefer FS, Brophy PD (2013) Urinary metabolomic markers of aminoglycoside nephrotoxicity in newborn rats. Pediatr Res 73(5):585–591
21. Beger RD, Holland RD, Sun J, Schnackenberg LK, Moore PC, Dent CL, Devarajan P, Portilla D (2008) Metabonomics of acute kidney injury in children after cardiac surgery. Pediatr Nephrol 23(6):977–984
22. Atzori L, Antonucci R, Barberini L, Locci E, Cesare Marincola F, Scano P, Cortesi P, Agostiniani R, Weljie A, Lai A, Fanos V (2010) 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Front Biosci 2:725–732
23. Atzori L, Mussap M, Noto A, Barberini L, Puddu M, Coni E, Murgia F, Lussu M, Fanos V (2011) Clinical metabolomics and urinary NGAL for the early prediction of chronic kidney disease in healthy adults born ELBW. J Matern Fetal Neonatal Med 24 [Suppl 2]:40–43
24. Zivkovic AM, Yang J, Georgi K, Hegedus C, Nording ML, O’Sullivan A, German JB, Hogg RJ, Weiss RH, Bay C, Hammock BD (2012) Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. Metabolomics 8(6):1102–1113
25. Peretz H, Watson DG, Blackburn G, Zhang T, Lagziel A, Shtauber-Naamati M, Morad T, Keren-Tardai E, Greenshpun V, Usher S, Shalev H, Landau D, Levartovsky D (2011) Urine metabolomics reveals novel physiologic functions of human aldehyde oxidase and provides biomarkers for typing xanthinuria. Metabolomics 8(5):951–959
26. Fanos V, Fanni C, Ottonello G, Noto A, Dessi A, Mussap M (2013) Metabolomics in adult and pediatric nephrology. Molecules 18(5):4844–4857